Long Haul COVIDSymptoms, Doctors, Treatments, Advances & More
Learn About Long Haul COVID
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
University Of Iowa Stead Family Children's Hospital
Alejandro Comellas is an Intensive Care Medicine provider practicing medicine in Iowa City, Iowa. Dr. Comellas is rated as an Elite provider by MediFind in the treatment of Long Haul COVID. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Long Haul COVID, Emphysema, Bronchitis, and Endoscopy.
Stanford Hospital And Clinics
Hector Bonilla is an Infectious Disease provider practicing medicine in Palo Alto, California. Dr. Bonilla is rated as an Elite provider by MediFind in the treatment of Long Haul COVID. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Long Haul COVID, MAGIC Syndrome, Severe Acute Respiratory Syndrome (SARS), and Mononucleosis.
Office
Linda Geng is a primary care provider, practicing in Internal Medicine in Atherton, California. Dr. Geng is rated as an Elite provider by MediFind in the treatment of Long Haul COVID. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Long Haul COVID, Severe Acute Respiratory Syndrome (SARS), Anosmia, and COVID-19.
Background: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from COVID-19 have symptoms that last long after the active infection ends. This is called long COVID. Sometimes, long COVID can affect the nerves and cause problems with sleep, thinking, the senses, and movement. Researchers want to find out whether people with long COVID have retained inactive remnants of SARS-CoV-2 in their b...
Objective: To observe and document symptom progression in 50 ME/CFS or PCS patients undergoing IA, and to examine whether changes in memory B-cells before treatment are linked to therapeutic response. The study is conducted as a non-interventional observational study. IA using the TheraSorb® column (Miltenyi) is performed within its approved clinical application.